Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 126 clinical trials
A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

The investigators hypothesized that clopidogrel mono-therapy will not be inferior to the extended DAPT in terms of the occurrence of both ischemic and bleeding events, for lesions or patients at high risk for either ischemic or bleeding complications 12 months after drug-eluting stent (DES) implantation.

  • 0 views
  • 23 Jan, 2021
Ticagrelor Versus Clopidogrel in Carotid Artery Stenting

Patients with symptomatic or asymptomatic carotid stenosis in whom carotid artery stenting is planned are randomised between antiplatelet therapy with ticagrelor plus aspirin or clopidogrel plus

amaurosis fugax
atherosclerosis
clopidogrel
ticagrelor
MRI
  • 52 views
  • 03 Feb, 2021
  • 21 locations
Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial

-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events.

coronavirus infection
blood clot
SARS
heparin
anticoagulation therapy
  • 50 views
  • 24 Jan, 2021
  • 1 location
TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI

] and aspirin) and late (>6-month post-PCI) deescalated (clopidogrel alone) strategy in patients undergoing high-risk complex PCI as compared with standard Dual Antiplatelet Therapy(aspirin and

aspirin
diabetes
percutaneous coronary intervention
  • 7 views
  • 25 Jan, 2021
  • 15 locations
Interest of S100B Protein for Patient Victim of Minor Traumatic Brain Injury and Treated by Antiplatelet

All the patients admitted in emergency department for minor traumatized cranial, with antiplatelet therapy, can be included, after checked inclusion and non inclusions criterias. If they are

  • 2 views
  • 29 Jan, 2021
  • 5 locations
STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction

half-dose tenecteplase and additional antiplatelet therapy with a loading dose of 300 mg clopidogrel, aspirin and coupled with antithrombin therapy followed by catheterisation within 6-24 hours or

antiplatelet therapy
aspirin
angiography
stemi
infarct
  • 125 views
  • 23 Jan, 2021
  • 51 locations
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event

coronary artery bypass graft
vitamin k
dabigatran
ticagrelor
anticoagulation therapy
  • 112 views
  • 04 Apr, 2021
  • 77 locations
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of antiplatelet therapy in patients

  • 45 views
  • 15 Apr, 2021
  • 260 locations
The Randomized OPTIMAL-ACT Trial

small caliber equipment is preferable, and where rates of intracoronary stenting and dual antiplatelet therapy use is high, lower ACT targets, as compared with higher ACT targets, will be associated

antiplatelet therapy
coronary revascularization
intravascular ultrasound
heparin
revascularisation
  • 0 views
  • 14 Feb, 2021
  • 1 location
Multivessel TALENT

the latest evidence, such as physiological assessment using quantitative flow ratio and prasugrel monotherapy following 1-month dual antiplatelet therapy after PCI.

  • 0 views
  • 11 Mar, 2021
  • 1 location